Investigation of Cryoport, Inc. (CYRX) Announced by Holzer & Holzer, LLC

Author's Avatar
Jul 17, 2023

ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cryoport, Inc. (“Cryoport,” or the “Company”) ( CYRX) complied with federal securities laws. On July 12, 2023, Cryoport announced preliminary financial results for the second quarter ended June 30, 2023, disclosing that “[s]econd quarter 2023 total revenue is expected to be in the range of $56.5 to $57.5 million, representing a decrease of 11%, at the midpoint, compared to the second quarter of 2022. These results reflect weaker than expected global demand for capital equipment; clinical trial start delays; and slower than expected ramps from certain clients.” Following this news, the price of the Company’s stock dropped.

If you purchased Cryoport stock and suffered a loss on that investment, you are encouraged to contact Marshall Dees, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/cryoport/ to discuss your legal rights.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. 

CONTACT: 
Marshall Dees, Esq.
(888) 508-6832 (toll-free)
[email protected]

ti?nf=ODg3NTU4NCM1Njk1MTE2IzIxODA3Njc=
Holzer-Holzer.png